Screening of esophageal varices in children using esophageal capsule endoscopy: a multicenter prospective study.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 6 9 2018
medline: 30 8 2019
entrez: 6 9 2018
Statut: ppublish

Résumé

Esophagogastroduodenoscopy (EGD) is the standard method for diagnosis of esophageal and gastric varices in children. In this prospective study we evaluated the use of PillCam esophageal capsule endoscopy (ECE) in pediatric patients. Patients aged 7 to 18 years presenting with portal hypertension and/or cirrhosis underwent ECE (PillCam ESO 2, Given Imaging Ltd.) followed by EGD. 102 patients were screened, 81 (52 boys; mean age 13.96 ± 0.25 years) were included and 21 were excluded (16 for "candy test" failure). Esophageal varices were identified by EGD in 62 patients (77 %) and by ECE in 57 patients (70 %) using the de Franchis classification (DFC). The sensitivity of ECE for esophageal varices was 92 % and the specificity was 100 % using DFC. Based upon 57/81 patients with small, medium, and large varices on both ECE and EGD, using DFC, the sensitivity, specificity, positive (PPV) and negative predictive value (NPV) were 55 %, 92 %, 89 %, and 63 %, respectively, giving a total overall accuracy of 72 %. To improve sensitivity and specificity in classification of esophageal varices, we propose using a modified score. This score detected esophageal varices with 100 % sensitivity, 93 % specificity, 94 % PPV, and 100 % NPV, giving a total overall accuracy of 97 %. All patients preferred ECE over EGD. No capsule retention was recorded. ECE is a well-tolerated and safe procedure in children. Using the modified score, the sensitivity of ECE is currently sufficient to detect esophageal varices and replace EGD in infants with suspicion of esophageal varices or when EGD is refused.

Sections du résumé

BACKGROUND
Esophagogastroduodenoscopy (EGD) is the standard method for diagnosis of esophageal and gastric varices in children. In this prospective study we evaluated the use of PillCam esophageal capsule endoscopy (ECE) in pediatric patients.
METHODS
Patients aged 7 to 18 years presenting with portal hypertension and/or cirrhosis underwent ECE (PillCam ESO 2, Given Imaging Ltd.) followed by EGD.
RESULTS
102 patients were screened, 81 (52 boys; mean age 13.96 ± 0.25 years) were included and 21 were excluded (16 for "candy test" failure). Esophageal varices were identified by EGD in 62 patients (77 %) and by ECE in 57 patients (70 %) using the de Franchis classification (DFC). The sensitivity of ECE for esophageal varices was 92 % and the specificity was 100 % using DFC. Based upon 57/81 patients with small, medium, and large varices on both ECE and EGD, using DFC, the sensitivity, specificity, positive (PPV) and negative predictive value (NPV) were 55 %, 92 %, 89 %, and 63 %, respectively, giving a total overall accuracy of 72 %. To improve sensitivity and specificity in classification of esophageal varices, we propose using a modified score. This score detected esophageal varices with 100 % sensitivity, 93 % specificity, 94 % PPV, and 100 % NPV, giving a total overall accuracy of 97 %. All patients preferred ECE over EGD. No capsule retention was recorded.
CONCLUSIONS
ECE is a well-tolerated and safe procedure in children. Using the modified score, the sensitivity of ECE is currently sufficient to detect esophageal varices and replace EGD in infants with suspicion of esophageal varices or when EGD is refused.

Identifiants

pubmed: 30184608
doi: 10.1055/a-0647-1709
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-17

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None

Auteurs

Jacques Cardey (J)

Gastroentérologie, hépatologie, nutrition pédiatrique, Hôpital Necker-Enfants malades, Paris, France.

Catherine Le Gall (C)

Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Hépatologie, gastroentérologie et nutrition pédiatrique, Lyon, France.

Laurent Michaud (L)

Gastroentérologie pédiatrique, CHRU Lille, Lille, France.

Alain Dabadie (A)

Hépatologie, gastroentérologie et nutrition pédiatrique, CHU Hôpital Sud, Rennes, France.

Cécile Talbotec (C)

Gastroentérologie, hépatologie, nutrition pédiatrique, Hôpital Necker-Enfants malades, Paris, France.

Marc Bellaiche (M)

Gastroentérologie et nutrition pédiatrique, Hôpital Robert Debré, Paris, France.

Thierry Lamireau (T)

Gastroentérologie pédiatrique, CHU Bordeaux, Bordeaux, France.

Emmanuel Mas (E)

Gastroentérologie, hépatologie, nutrition, diabétologie pédiatrique, CHU Toulouse, Toulouse, France.

Laure Bridoux-Henno (L)

Hépatologie, gastroentérologie et nutrition pédiatrique, CHU Hôpital Sud, Rennes, France.

Jerome Viala (J)

Gastroentérologie et nutrition pédiatrique, Hôpital Robert Debré, Paris, France.

Lioara Restier-Miron (L)

Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Hépatologie, gastroentérologie et nutrition pédiatrique, Lyon, France.

Alain Lachaux (A)

Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Hépatologie, gastroentérologie et nutrition pédiatrique, Lyon, France.
Université Cl Bernard Lyon 1, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH